View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 17, 2021updated 07 Jan 2022 8:47am

Ethos unveils new sample collection kit for Covid-19 antibody test

The new self-collection kit allows individuals to measure their current immunity levels against Covid-19.

Ethos Laboratories has launched the new fingerstick self-blood collection kit, Tru-Immune, for its Covid-19 neutralising antibody test.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

The kit provides quantitative data regarding the viral blocking efficacy of neutralising antibodies.

Individuals can use the kit to measure their current immunity levels against Covid-19 safely, rapidly and efficiently in real-time with less pain.

Additionally, it will help people monitor their neutralising antibody level and reduce the chances to get infected.

The Tru-Immune uses a simple drop of capillary blood from the patients’ fingertip, which will be returned to Ethos through prepaid and priority postage. It delivers the results in 48 hours electronically.

Ethos Laboratories CEO Brian Kincaid said: “As we enter year three of the Covid-19 global pandemic, the question is no longer, ‘Do I have Covid-19 antibodies?’ Instead, people are asking themselves, ‘What level of protective immunity do I have against future infection and do I need a vaccine booster?’ These questions can now be answered with Tru-Immune.”

The Covid-19 neutralising antibody tests will provide information regarding the immunity levels against the disease in the individual.

This will help the healthcare provider to make decisions regarding vaccination and booster schedules.

Ethos noted that the neutralising antibody assays like Tru-Immune are expected to become the assay of choice to record natural immunity in states, where employers need proof to get exemption from mandates with regard to vaccines.

In April, Ethos introduced a new molecular test to detect key virus strains of SARS-CoV-2, including the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1) variants.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network